Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients
NCT00982995
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
site terminated due to lack of enrollment
Conditions
Nausea
Vomiting
Terminally Ill
Interventions
DRUG:
Palonosetron
Sponsor
University of Michigan Rogel Cancer Center